Literature DB >> 12889293

Delay in starting treatment for tuberculosis in east London.

K E Lewis1, C Stephens, M M Shahidi, G Packe.   

Abstract

In the United Kingdom there is little information about the delay between the onset of symptoms in patients with tuberculosis and the time it takes for them to be correctly diagnosed and treatment started. We have examined the duration and possible causes of such delay in our own district. The records of 93 patients were examined. Total delay in starting treatment was estimated as the time from the start of symptoms to commencement of chemotherapy. Patient delays were estimated from the time between the start of symptoms to the time taken to first attend their general practitioner (GP) with symptoms. Healthcare system delays were estimated from the interval between first being assessed by their GP and starting anti-tuberculosis treatment. Median total delay was 18 weeks (0-219). The time when patients first presented to their GP was determined for 64 patients: median patient delay was then estimated as nine weeks (range 0-104 weeks), and median healthcare delay five weeks, with a very wide range (0.5-210). Prolonged delay was seen in three patients with cervical lymph node disease. Patient delay was significantly longer than healthcare system delay (p = 0.019). Pulmonary disease was associated with shorter total delay in starting treatment compared with extra-pulmonary disease (p = 0.035). In patients with tuberculosis there were considerable delays in first presentation to medical services, in diagnosis and in starting treatment. Patient delays were longer than healthcare system delays. There is a need to improve awareness of the symptoms of tuberculosis both on the part of the general population and of health professionals, especially in areas of high incidence.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12889293

Source DB:  PubMed          Journal:  Commun Dis Public Health        ISSN: 1462-1843


  11 in total

1.  Diagnostic and treatment delay among Tuberculosis patients in Afar Region, Ethiopia: a cross-sectional study.

Authors:  Mulugeta Belay; Gunnar Bjune; Gobena Ameni; Fekadu Abebe
Journal:  BMC Public Health       Date:  2012-05-23       Impact factor: 3.295

2.  Pastoralism and delay in diagnosis of TB in Ethiopia.

Authors:  Abdi A Gele; Gunnar Bjune; Fekadu Abebe
Journal:  BMC Public Health       Date:  2009-01-07       Impact factor: 3.295

3.  Patient and health care system delays in the start of tuberculosis treatment in Norway.

Authors:  Mohamed Guled Farah; Jens Henning Rygh; Tore W Steen; Randi Selmer; Einar Heldal; Gunnar Bjune
Journal:  BMC Infect Dis       Date:  2006-02-24       Impact factor: 3.090

4.  Genital tuberculosis in a tamoxifen-treated postmenopausal woman with breast cancer and bloody vaginal discharge.

Authors:  Ioannis Neonakis; Elpis Mantadakis; Zoe Gitti; Ioanna Mitrouska; Louis George Manidakis; Sofia Maraki; George Samonis
Journal:  Ann Clin Microbiol Antimicrob       Date:  2006-09-01       Impact factor: 3.944

5.  Risk factors for treatment delay in pulmonary tuberculosis in Recife, Brazil.

Authors:  Martinho A P S dos Santos; Maria F P M Albuquerque; Ricardo A A Ximenes; Norma L C L Lucena-Silva; Cynthia Braga; Antônio R L Campelo; Odimariles M S Dantas; Ulisses R Montarroyos; Wayner V Souza; Alexandre M Kawasaki; Laura C Rodrigues
Journal:  BMC Public Health       Date:  2005-03-18       Impact factor: 3.295

6.  [Pulmonary tuberculosis mortality risk factors].

Authors:  Hicham Janah; Hicham Souhi; Hatim Kouismi; Karima Mark; Rachida Zahraoui; Jouda Benamor; Mona Soualhi; Jamal Eddine Bourkadi
Journal:  Pan Afr Med J       Date:  2014-12-03

7.  Factors associated with patient and health system delays in diagnosis and treatment of tuberculosis in Montenegro, 2015-2016.

Authors:  Olivera Bojovic; Milic Medenica; Danko Zivkovic; Bozidarka Rakocevic; Goran Trajkovic; Darija Kisic-Tepavcevic; Anita Grgurevic
Journal:  PLoS One       Date:  2018-03-09       Impact factor: 3.240

8.  Time to diagnosis of tuberculosis is greater in older patients: a retrospective cohort review.

Authors:  Aula Abbara; Simon M Collin; Onn M Kon; Kevin Buell; Adam Sullivan; Jessica Barrett; Tumena Corrah; Alastair McGregor; Trevor Hansel; Laurence John; Robert N Davidson
Journal:  ERJ Open Res       Date:  2019-11-04

9.  Health care seeking patterns of rifampicin-resistant tuberculosis patients in Harare, Zimbabwe: A prospective cohort study.

Authors:  Rebecca Tadokera; Stella Huo; Grant Theron; Collins Timire; Salome Manyau-Makumbirofa; John Z Metcalfe
Journal:  PLoS One       Date:  2021-07-16       Impact factor: 3.240

Review 10.  A systematic review of delay in the diagnosis and treatment of tuberculosis.

Authors:  Dag Gundersen Storla; Solomon Yimer; Gunnar Aksel Bjune
Journal:  BMC Public Health       Date:  2008-01-14       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.